Former Oracle leader joins to advance launch intelligence innovation
Within3, the leading Launch Intelligence™ platform for life science, today announced the appointment of Ian McKinnon, Ph.D., as Managing Director, Global Head of Consulting. McKinnon joins from Oracle, where he most recently served as Global Head of Commercial Consulting, Life Sciences.
With more than two decades of experience guiding pharmaceutical and biotech companies through complex commercialization challenges, McKinnon has held senior leadership roles at Oracle, Cerner, Kantar Health, and TNS Healthcare. His expertise spans launch excellence, evidence-based strategy, advanced analytics, and the application of AI and machine learning to real-world data.
“Bringing Ian on board is another signal of our ambition to redefine how life sciences organizations approach launch,” said Lance Hill, CEO of Within3. “Top industry leaders don’t leave Oracle to join just any company. Ian’s decision underscores the disruptive work we’re doing with Launch Intelligence™ and reinforces our reputation as the partner driving pharma’s next era of innovation.”
In his new role, McKinnon will accelerate the growth of Within3’s Launch Intelligence™ platform and services, ensuring clients capture maximum value from real-time, decision-ready insights. He will lead initiatives that help pharmaceutical brand, medical, and field teams unify fragmented data, anticipate market shifts, and act with confidence at every stage of launch. By combining deep commercialization expertise with Within3’s proprietary technology, McKinnon will help expand the company’s ability to deliver intelligence and guidance that enable life science organizations to launch with confidence.
“Joining Within3 is about being part of a visionary organization,” said McKinnon. “The company is building something that simply does not exist elsewhere in the industry, and it’s an opportunity to apply my experience to a team that is setting the pace for how launches succeed in pharma.”
This leadership appointment comes as Within3 continues rapid growth, expanding its Launch Intelligence™ platform and services to support pharmaceutical companies across the launch lifecycle.
